Last updated on August 2019

A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis.


Brief description of study

This is a phase 2 study to evaluate safety and efficacy of ABBV-105 and ABBV-599 (ABBV-105 plus upadacitinib) vs placebo on a background of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDS) for the treatment of signs and symptoms of Rheumatoid Arthritis (RA) at 12 weeks in biological disease-modifying anti-rheumatic drugs(bDMARD)-inadequate response (bDMARD-IR) or bDMARD-intolerant participants with moderately to severely active RA and to define optimal dose for further development.

Clinical Study Identifier: NCT03682705

Find a site near you

Start Over

Valerius Medical Group /ID# 168123

Los Alamitos, CA United States
2.18miles
  Connect »

St. Jude Heritage /ID# 167379

Fullerton, CA United States
9.41miles
  Connect »

St. Joseph Heritage Healthcare /ID# 167379

Fullerton, CA United States
9.41miles
  Connect »